COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January–June 2020, in the United States
| Autor: | Tanner Rockwell, Mona Saraiya, Stephanie Melillo, J Sun, J Uhd, Lisa C. Richardson, Amy DeGroff, Krishna P. Sharma, A Sheu, W. Helsel, Faye Wong, Jacqueline W. Miller, W. Kammerer, Kristy Kenney |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Epidemiology New York Ethnic group Uterine Cervical Neoplasms Breast Neoplasms 01 natural sciences Article 03 medical and health sciences Breast cancer screening 0302 clinical medicine Cancer screening Health care Pandemic Ethnicity Humans Mass Screening Medicine 030212 general & internal medicine 0101 mathematics Early Detection of Cancer Minority Groups Mass screening Medically Uninsured medicine.diagnostic_test SARS-CoV-2 business.industry Public health 010102 general mathematics Public Health Environmental and Occupational Health COVID-19 United States Female Rural area business Demography |
| Zdroj: | Prev Med |
| ISSN: | 0091-7435 |
| Popis: | Women from racial and ethnic minority groups face a disproportionate burden of cervical and breast cancers in the United States. The Coronavirus Disease 2019 (COVID-19) pandemic might exacerbate these disparities as supply and demand for screening services are reduced. The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides cancer screening services to women with low income and inadequate health insurance. We examined COVID-19's impact on NBCCEDP screening services during January-June 2020. We found the total number of NBCCEDP-funded breast and cervical cancer screening tests declined by 87% and 84%, respectively, during April 2020 compared with the previous 5-year averages for that month. The extent of declines varied by geography, race/ethnicity, and rurality. In April 2020, screening test volume declined most severely in Health and Human Services Region 2 - New York (96% for breast, 95% for cervical cancer screening) compared to the previous 5-year averages. The greatest declines were among American Indian/Alaskan Native women for breast cancer screening (98%) and Asian Pacific Islander women for cervical cancer screening (92%). Test volume began to recover in May and, by June 2020, NBCCEDP breast and cervical cancer screening test volume was 39% and 40% below the 5-year average for that month, respectively. However, breast cancer screening remained over 50% below the 5-year average among women in rural areas. NBCCEDP programs reported assisting health care providers resume screening. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect